Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Camp Hill, Pa.-based drugstore chain Rite Aid will pay $4 million to settle a U.S. Department of Justice criminal investigation into the improper sale of an ingredient often used to make methamphetamine, reports Reuters.
The FDA prolonged the shelf life of numerous IV solutions manufactured by Baxter International amid an ongoing nationwide shortage.
Amazon is expanding its healthcare team focused on a potential pharmacy market entrance, according to a report from the financial research firm Leerink cited by CNBC.
Drug companies are taking steps to address the growing threat of drug-resistant bacteria, but these actions are still in early phases, according to an analysis from the nonprofit group Access to Medicine Foundation.
Dan Liljenquist, vice president of the enterprise initiative office at Salt Lake City-based Intermountain Healthcare, is fully aware of the high costs and shortages of generic drugs.
Congress voted in favor of a stopgap spending bill Monday that ended the government shutdown and further delayed the enforcement of a 2.3 percent medical device tax, reports STAT.
The FDA approved Baxter International's cardiovascular medication Bivalirudin Monday.
Here are seven drug and medical device companies that made headlines in the past week.
New Jersey's Office of the Attorney General finalized rules limiting drug companies' payments and gifts to healthcare providers, reports Policy and Medicine.
Prescriptions for Tamiflu have seen a more than six-fold increase this flu season compared to last year, according to an analysis from GoodRx.